ingersoll rand inc. - IR
IR
Close Chg Chg %
103.05 1.67 1.62%
Open Market
104.72
+1.67 (1.62%)
Volume: 603.04K
Last Updated:
Nov 22, 2024, 1:03 PM EDT
Company Overview: ingersoll rand inc. - IR
IR Key Data
| Open $102.56 | Day Range 102.56 - 104.96 |
| 52 Week Range 69.46 - 105.63 | Market Cap $41.53B |
| Shares Outstanding 403.01M | Public Float 402.19M |
| Beta 1.42 | Rev. Per Employee N/A |
| P/E Ratio 50.08 | EPS $2.08 |
| Yield 7.76% | Dividend $0.02 |
| EX-DIVIDEND DATE Nov 14, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.28M |
IR Performance
| 1 Week | 0.60% | ||
| 1 Month | 7.20% | ||
| 3 Months | 12.44% | ||
| 1 Year | 44.46% | ||
| 5 Years | 206.12% |
IR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
18
Full Ratings ➔
About ingersoll rand inc. - IR
Ingersoll Rand Inc. engages in the provision of services and solutions through air, fluid, energy, and medical technologies. It operates through two segments: Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment provides compressor, vacuum, blower solutions, and industrial technologies such as power tools and lifting equipment. The Precision and Science Technologies segment includes fluid management solutions such as precision liquid and gas pumps, and niche compression technologies. The company was founded in 1872 and is headquartered in Davidson, NC.
IR At a Glance
Ingersoll Rand, Inc.
525 Harbor Place Drive
Davidson, North Carolina 28036
| Phone | 1-704-655-4000 | Revenue | 6.88B | |
| Industry | Industrial Machinery | Net Income | 778.70M | |
| Sector | Producer Manufacturing | 2023 Sales Growth | 16.223% | |
| Fiscal Year-end | 12 / 2024 | Employees | 18,000 | |
| View SEC Filings |
IR Valuation
| P/E Current | 50.083 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 40.622 |
| Price to Sales Ratio | 4.60 |
| Price to Book Ratio | 3.188 |
| Price to Cash Flow Ratio | 22.965 |
| Enterprise Value to EBITDA | 19.281 |
| Enterprise Value to Sales | 4.797 |
| Total Debt to Enterprise Value | 0.087 |
IR Efficiency
| Revenue/Employee | 382,005.556 |
| Income Per Employee | 43,261.111 |
| Receivables Turnover | 5.571 |
| Total Asset Turnover | 0.453 |
IR Liquidity
| Current Ratio | 2.217 |
| Quick Ratio | 1.669 |
| Cash Ratio | 0.873 |
IR Profitability
| Gross Margin | 36.572 |
| Operating Margin | 18.201 |
| Pretax Margin | 14.995 |
| Net Margin | 11.325 |
| Return on Assets | 5.135 |
| Return on Equity | 8.206 |
| Return on Total Capital | 6.148 |
| Return on Invested Capital | 6.334 |
IR Capital Structure
| Total Debt to Total Equity | 29.458 |
| Total Debt to Total Capital | 22.755 |
| Total Debt to Total Assets | 18.518 |
| Long-Term Debt to Equity | 28.72 |
| Long-Term Debt to Total Capital | 22.185 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Ingersoll Rand Inc. - IR
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 4.91B | 5.15B | 5.92B | 6.88B | |
Sales Growth
| +100.26% | +4.93% | +14.83% | +16.22% | |
Cost of Goods Sold (COGS) incl D&A
| 3.69B | 3.50B | 3.94B | 4.36B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 500.90M | 422.10M | 432.80M | 459.10M | |
Depreciation
| 105.10M | 89.20M | 85.20M | 91.60M | |
Amortization of Intangibles
| 395.80M | 332.90M | 347.60M | 367.50M | |
COGS Growth
| +120.59% | -5.30% | +12.63% | +10.74% | |
Gross Income
| 1.22B | 1.66B | 1.98B | 2.51B | |
Gross Income Growth
| +56.52% | +35.97% | +19.47% | +27.13% | |
Gross Profit Margin
| +24.80% | +32.13% | +33.43% | +36.57% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 889.80M | 1.02B | 1.09B | 1.27B | |
Research & Development
| 71.00M | 74.00M | 91.00M | 108.00M | |
Other SG&A
| 818.80M | 948.60M | 1.00B | 1.16B | |
SGA Growth
| +108.43% | +14.92% | +6.86% | +16.19% | |
Other Operating Expense
| 6.10M | 5.20M | 5.40M | (6.50M) | |
Unusual Expense
| 217.10M | 83.10M | 69.50M | 95.60M | |
EBIT after Unusual Expense
| 104.60M | 544.70M | 810.30M | 1.16B | |
Non Operating Income/Expense
| (31.40M) | 56.00M | 26.40M | (2.70M) | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 92.60M | 87.70M | 94.50M | 122.10M | |
Interest Expense Growth
| +26.33% | -5.29% | +7.75% | +29.21% | |
Gross Interest Expense
| 92.60M | 87.70M | 94.50M | 122.10M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (19.40M) | 513.00M | 742.20M | 1.03B | |
Pretax Income Growth
| -110.16% | +2,744.33% | +44.68% | +38.92% | |
Pretax Margin
| -0.40% | +9.96% | +12.55% | +15.00% | |
Income Tax
| 13.00M | (21.80M) | 149.60M | 240.00M | |
Income Tax - Current - Domestic
| 37.90M | (27.30M) | 88.00M | 135.20M | |
Income Tax - Current - Foreign
| 79.50M | 109.10M | 147.40M | 181.70M | |
Income Tax - Deferred - Domestic
| (58.90M) | (20.40M) | (42.80M) | (50.90M) | |
Income Tax - Deferred - Foreign
| (45.50M) | (83.20M) | (43.00M) | (26.00M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (32.40M) | 523.40M | 593.30M | 785.10M | |
Minority Interest Expense
| 900.00K | 2.50M | 3.80M | 6.40M | |
Net Income
| (33.30M) | 520.90M | 589.50M | 778.70M | |
Net Income Growth
| -120.93% | +1,664.26% | +13.17% | +32.09% | |
Net Margin Growth
| -0.68% | +10.11% | +9.96% | +11.32% | |
Extraordinaries & Discontinued Operations
| - | - | (49.00M) | 18.00M | - |
Discontinued Operations
| - | - | (49.00M) | 18.00M | - |
Net Income After Extraordinaries
| (33.30M) | 471.90M | 607.50M | 778.70M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (33.30M) | 471.90M | 607.50M | 778.70M | |
EPS (Basic)
| -0.087 | 1.1377 | 1.4989 | 1.9237 | |
EPS (Basic) Growth
| -111.13% | +1,407.70% | +31.75% | +28.34% | |
Basic Shares Outstanding
| 382.80M | 414.80M | 405.30M | 404.80M | |
EPS (Diluted)
| -0.087 | 1.1204 | 1.481 | 1.9039 | |
EPS (Diluted) Growth
| -111.42% | +1,387.82% | +32.18% | +28.56% | |
Diluted Shares Outstanding
| 382.80M | 421.20M | 410.20M | 409.00M | |
EBITDA
| 822.60M | 1.05B | 1.31B | 1.71B | |
EBITDA Growth
| +56.03% | +27.63% | +25.02% | +30.32% | |
EBITDA Margin
| +16.75% | +20.38% | +22.19% | +24.88% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 109.214 | |
| Number of Ratings | 18 | Current Quarters Estimate | 0.854 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 3.301 | |
| Last Quarter’s Earnings | 0.84 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.96 | Next Fiscal Year Estimate | 3.533 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 14 | 10 | 15 | 15 |
| Mean Estimate | 0.85 | 0.79 | 3.30 | 3.53 |
| High Estimates | 0.88 | 0.81 | 3.33 | 3.65 |
| Low Estimate | 0.84 | 0.76 | 3.17 | 3.40 |
| Coefficient of Variance | 1.58 | 2.31 | 1.19 | 1.95 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 7 | 7 | 7 |
| OVERWEIGHT | 2 | 2 | 2 |
| HOLD | 7 | 7 | 7 |
| UNDERWEIGHT | 2 | 1 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Ingersoll Rand Inc. - IR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Ingersoll Rand Inc. - IR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Nov 8, 2024 | Joanna L. Sohovich Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 8, 2024 | Julie A. Schertell Director | 663 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 8, 2024 | Michael Joseph Scheske VP, Chief Accounting Officer | 11,910 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $97.44 per share | 1,160,510.40 |
| Nov 8, 2024 | Julie A. Schertell Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 8, 2024 | Joanna L. Sohovich Director | 758 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 8, 2024 | Michael Joseph Scheske VP, Chief Accounting Officer | 14,441 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $27.05 per share | 390,629.05 |
| Nov 8, 2024 | Andrew Roger Schiesl See Remarks | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 8, 2024 | Michael Joseph Scheske VP, Chief Accounting Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 8, 2024 | Andrew Roger Schiesl See Remarks | 55,080 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $27.79 per share | 1,530,673.20 |
| Nov 8, 2024 | Andrew Roger Schiesl See Remarks | 30,846 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $95.08 per share | 2,932,837.68 |
| Aug 23, 2024 | Michael A. Weatherred See Remarks | 9,363 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 23, 2024 | Elizabeth Meloy Hepding See Remarks | 1,740 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 23, 2024 | Elizabeth Meloy Hepding See Remarks | 4,213 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 23, 2024 | Michael A. Weatherred See Remarks | 3,867 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 23, 2024 | Kathleen M. Keene See Remarks | 1,933 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 23, 2024 | Vikram Kini Senior Vice President and CFO | 8,694 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 23, 2024 | Elizabeth Meloy Hepding See Remarks | 14,059 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $49.52 per share | 696,201.68 |
| Aug 23, 2024 | Elizabeth Meloy Hepding See Remarks | 6,559 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $91.42 per share | 599,623.78 |
| Aug 23, 2024 | Elizabeth Meloy Hepding See Remarks | 18,246 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Aug 23, 2024 | Vikram Kini Senior Vice President and CFO | 3,591 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |